Background: Volatile anesthetics produce cardioprotective action by attenuating cellular Ca 2ϩ overload. The Ca 2ϩ paradox is an important model for studying the mechanisms associated with Ca 2ϩ overload-mediated myocardial injury, and was recently found to be mediated by Ca 2ϩ entry through the transient receptor potential canonical channels upon Ca 2ϩ repletion. This study investigated the effect of sevoflurane on cellular mechanisms underlying the Ca
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Background: Volatile anesthetics produce cardioprotective action by attenuating cellular Ca 2ϩ overload. The Ca 2ϩ paradox is an important model for studying the mechanisms associated with Ca 2ϩ overload-mediated myocardial injury, and was recently found to be mediated by Ca 2ϩ entry through the transient receptor potential canonical channels upon Ca 2ϩ repletion. This study investigated the effect of sevoflurane on cellular mechanisms underlying the Ca 2ϩ paradox. Methods: The Ca 2ϩ paradox was examined in fluo-3 or mag-fluo-4-loaded mouse ventricular myocytes using confocal laser scanning microscope, upon Ca 2ϩ repletion after 15 min of Ca 2ϩ depletion in the absence and presence of sevoflurane. Results: The Ca 2ϩ paradox was evoked in approximately 65% of myocytes upon Ca 2ϩ repletion, as determined by an abrupt elevation of cytosolic Ca 2ϩ accompanied by hypercontracture. The Ca 2ϩ paradox was significantly suppressed by sevoflurane administered for 3 min before and during Ca 2ϩ repletion (Post) or during Ca 2ϩ depletion and repletion (Postlong), and Postlong was more beneficial than Post application. The sarcoplasmic reticulum Ca 2ϩ levels gradually decreased during Ca 2ϩ depletion, and the Ca 2ϩ paradox was readily evoked in myocytes with reduced sarcoplasmic reticulum Ca 2ϩ levels. Postlong but not Post application of sevoflurane prevented decrease in sarcoplasmic reticulum Ca 2ϩ levels by blocking Ca 2ϩ leak through ryanodine receptors. Whole cell patch-clamp recordings revealed that sevoflurane rapidly blocked thapsigargin-induced transient receptor potential canonical currents. Conclusions: Sevoflurane protects ventricular myocytes from Ca 2ϩ paradox-mediated Ca 2ϩ overload by blocking transient receptor potential canonical channels and by preventing the decrease in sarcoplasmic reticulum Ca 2ϩ levels, which is associated with less activation of transient receptor potential canonical channels.
A
NUMBER of studies have demonstrated that volatile anesthetics such as sevoflurane and isoflurane protect the heart from ischemia/reperfusion injury when administered before ischemia (anesthetic preconditioning, APC) [1] [2] [3] [4] or even immediately upon reperfusion (anesthetic postcon-
What We Already Know about This Topic
• The Ca 2ϩ paradox is the rapid deterioration of the heart as a result of Ca 2ϩ overload on reperfusion after a period of Ca 2ϩ depletion, and is primarily mediated by Ca 2ϩ entry via the transient receptor potential canonical channels
What This Article Tells Us That Is New
• Sevoflurane blocks the transient receptor potential canonical channel in mouse ventricular myocytes at clinically relevant concentrations, thereby preventing the Ca 2ϩ paradox • Sevoflurane helps preserve sarcoplasmic reticulum Ca 2ϩ levels during Ca 2ϩ depletion by blocking its spontaneous release in mouse ventricular myocytes Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are available in both the HTML and PDF versions of this article. Links to the digital files are provided in the HTML text of this article on the Journal's Web site (www.anesthesiology.org).
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September 2011ditioning, APoC). [5] [6] [7] Several cellular mechanisms have been proposed to mediate the beneficial effects of APoC, such as activation of protein kinase C and phosphatidylinositol-3-kinase, or inhibition of glycogen synthase kinase-3␤ and mitochondrial permeability transition pore. 6,8 -10 Because myocardial reperfusion injury occurs within the first few minutes of reperfusion after ischemia, 11 it seems unlikely that the prosurvival signaling pathways implicated in APoC give rise to adequate protective effects on initial injury during reperfusion. On the other hand, an excessive accumulation of intracellular Ca 2ϩ occurs during the early reperfusion phase and leads to various cellular injuries associated with ischemia/reperfusion. 12, 13 Experimental evidence has been presented to indicate that volatile anesthetics substantially attenuate Ca 2ϩ overload upon the onset of reperfusion and thereby produce an APoC action in the heart. 5, 7 However, the mechanisms by which volatile anesthetics ameliorate cellular Ca 2ϩ overload have yet to be fully characterized. The Ca 2ϩ paradox rapidly develops upon repletion of Ca 2ϩ to the heart after a brief period of Ca 2ϩ depletion. [13] [14] [15] There are some similarities in the structural and functional alterations caused by the Ca 2ϩ paradox and those induced by reoxygenation after anoxia or ischemia, such as Ca 2ϩ overload-mediated hypercontracture, mitochondrial dysfunction, and electrical and contractile disorders. These findings suggest that the Ca 2ϩ paradox is an important experimental model for investigating the cellular mechanisms associated with Ca 2ϩ overload-mediated injury during reperfusion of ischemic myocardium. 16 The transient receptor potential canonical (TRPC) channels are Ca 2ϩ -permeable nonselective cation channels that can be activated by a variety of signals, including depletion of endoplasmic reticulum/sarcoplasmic reticulum (SR) Ca 2ϩ stores. [17] [18] [19] TRPC channels have therefore been implicated in the store-operated Ca 2ϩ entry (SOCE) in various cell types. Recent studies suggest that stromal interacting molecule 1 and Orai1 interact with TRPC proteins to mediate SOCE in some cell types. 20, 21 There is accumulating evidence that TRPC channels are involved in diverse physiologic and pathophysiologic processes in cardiac cells. 22, 23 The human myocardium expresses multiple TRPC channel isoforms such as TRPC1, TRPC4, TRPC5, and TRPC6, 24 and TRPC-mediated Ca 2ϩ entry is implicated in the development of hypertrophic phenotype in humans 24 and experimental animal models. 25, 26 Our recent study has demonstrated that in mouse ventricular myocytes, the Ca 2ϩ paradox is primarily mediated by Ca 2ϩ entry through TRPC channels (probably TRPC1) upon restoration of extracellular Ca 2ϩ . 27 Furthermore, recent evidence indicates that the SOCE-mediated Ca 2ϩ entry contributes to the occurrence of ischemia/reperfusion-induced Ca 2ϩ overload in the heart. 28, 29 The current investigation examined the effect of sevoflurane on the cellular and electrophysiological mechanisms associated with Ca 2ϩ paradox-mediated Ca 2ϩ overload. Our results provide novel evidence that sevoflurane protects ventricular myocytes from the Ca  2ϩ paradox by two distinct but  closely related mechanisms, namely by blocking the TRPC  channel that enables Ca  2ϩ entry upon Ca  2ϩ repletion and by  preventing the decrease in Ca  2ϩ levels in the SR during Ca   2ϩ depletion, which is associated with less TRPC activation.
Materials and Methods

Preparation of Mouse Ventricular Myocytes
All of the experimental protocols are in conformance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (National Institutes of Health Publication no. 85-23, revised 1996) and were approved by the institutional Animal Care and Use Committee of Shiga University of Medical Science (Otsu, Shiga, Japan; no. 2010 -1-3). Ventricular myocytes were enzymatically dispersed from hearts of 7-to 10-week-old male C57BL/6J mice (body weight, 20 -25 g), as described previously. 27, 30 In brief, mice were killed by intraperitoneal injection of sodium pentobarbital overdose (300 mg/kg) with heparin (8,000 U/kg). The heart was excised and quickly cannulated via the ascending aorta, and retrograde perfusion was performed in a Langendorff apparatus at 37°C initially with normal Tyrode solution for 3 min, then with cell isolation buffer supplemented with 0.4 mM EGTA, for 3 min, and finally with cell isolation buffer supplemented with 1 mg/ml collagenase, 0.06 mg/ml trypsin, 0.06 mg/ml protease, and 0.3 mM CaCl 2 for 6 -10 min. The ventricles were cut, minced, and then gently agitated intermittently for 6 -8 min in cell isolation buffer supplemented with 1 mg/ml collagenase, 0.06 mg/ml trypsin, 0.06 mg/ml protease, 0.7 mM CaCl 2 , and 2 mg/ml bovine serum albumin. The supernatant containing isolated myocytes was centrifuged (14 g for 3 min) and the myocytes were suspended in cell isolation buffer supplemented with 1.2 mM CaCl 2 and 2 mg/ml bovine serum albumin. After 10 min of incubation, the cell suspension was again centrifuged and resuspended in normal Tyrode solution supplemented with 2 mg/ml bovine serum albumin and antibiotics (penicillin/streptomycin). This isolation procedure resulted in a high yield (70 -80%) of rodshaped quiescent ventricular myocytes in normal Tyrode solution. A previous study confirmed that ventricular myocytes isolated in this way have normal electrophysiologic and contractile properties.
30
Solutions and Chemicals
Normal Tyrode solution contained (in mM) 140 NaCl, 5. -free Tyrode solution is estimated to be in the range of a few to 20 M.
31,32
The extracellular solution used to measure whole cell TRPC currents was K ϩ -free Tyrode solution supplemented with nisoldipine, which contained (in mM) 140 NaCl, 1. MO) , and tetracaine (Sigma Chemical Company). Concentrated stock solutions were made for thapsigargin (10 mM) and 2-APB (20 mM) in dimethyl sulfoxide and diluted in bathing solutions at a final concentration as indicated. Caffeine and tetracaine were directly added to bathing solutions. Fluo-3 acetoxymethyl ester (fluo-3 AM) was from Dojin Chemicals (Kumamoto, Japan), and magfluo-4 AM and pluronic F-127 were from Molecular Probes (Eugene, OR). The cell isolation buffer used for cell preparation contained (in mM) 130 NaCl, 5.4 KCl, 0.5 MgCl 2 , 0.33 NaH 2 PO 4 , 22 glucose, 25 HEPES (pH adjusted to 7.4 with NaOH), and 50 U/ml bovine insulin. Collagenase (type 2) was obtained from Worthington Biochemical Corporation (Lakewood, NJ), and trypsin, protease, bovine serum albumin, and bovine insulin were from Sigma Chemical Company. experiments. An aliquot of fluo-3 or mag-fluo-4 loaded myocytes was allowed to settle onto the glass bottom of a recording chamber (0.5 ml in volume) mounted on the stage of an Eclipse TE2000-E inverted microscope (Nikon, Tokyo, Japan), equipped with a C1si spectral imaging confocal laser scanning system (Nikon). The chamber was continuously perfused with bathing solutions at a constant rate of 2-3 ml/min at room temperature (23-25°C). Fluo-3 or magfluo-4 loaded myocytes were excited with an argon laser beam (wavelength 488 nm) at 30-s or 10-s intervals, respectively, unless otherwise noted, and data were collected for emission intensity at wavelength of 515 nm. Fluorescence images were analyzed frame by frame using Nikon EZ-C1 software to calculate the average intensity in each myocyte, which was used as an estimate of cytosolic (fluo-3) or SR (mag-fluo-4) Ca 2ϩ levels. All intensity values were calculated by subtracting the background fluorescence. Changes in the cell morphology were also assessed by measuring a length/ width ratio in each myocyte image, and the myocytes showing the length/width ratio of less than 2 were considered to be either hypercontracted or dead. 35 The periods of exposure to various reagents and changes in extracellular Ca 2ϩ concentrations are denoted by horizontal bars or boxes in the figures. The data (fluorescence intensity and length/width ratio) for initial superfusion with normal Tyrode solution was shown for the latter 2 min. Fluorescence images were obtained from quiescent (not paced) mouse ventricular myocytes because myocytes failed to respond to electrical stimulation when superfused with nominally Ca 2ϩ -free Tyrode solution. Ventricular myocytes that generated spontaneous Ca 2ϩ waves during initial superfusion with normal Tyrode and/or subsequent superfusion with nominally Ca 2ϩ -free Tyrode solution were excluded from the analysis (less than approximately 2% of the total viable myocytes).
Protocols for Evaluation of Ca 2؉ Paradox in Fluo-3 Loaded Myocytes
To evoke the Ca 2ϩ paradox, ventricular myocytes loaded with fluo-3 were successively superfused, initially with normal Tyrode solution for 5 min, then with nominally Ca 2ϩ free-Tyrode solution for 15 min (Ca 2ϩ depletion), and again with normal Tyrode solution (Ca 2ϩ repletion). 27 Fluo-3 fluorescence images were obtained using a ϫ 10 objective lens, and approximately 20 rod-shaped viable myocytes were observed within a single field of view in a typical experiment. The incidence of the Ca 2ϩ paradox was measured in each experiment as a percentage of hypercontracted myocytes due to increased cytosolic Ca 2ϩ levels (as assessed by fluo-3 fluorescence intensity) upon Ca 2ϩ repletion with reference to the total number of rod-shaped viable myocytes during initial superfusion with normal Tyrode solution. tion, using a superfusion protocol similar to that for fluo-3-loaded myocytes. Mag-fluo-4 fluorescence images were captured using a ϫ40 objective lens, and 1-3 of viable myocytes were usually observed within a single field of view. Magfluo-4 fluorescence intensity (F) was expressed as relative value (F/F 0 ) compared with baseline value obtained just before Ca 2ϩ -free superfusion (F 0 ), unless otherwise stated. The occurrence of Ca 2ϩ paradox was assessed in each myocyte by cellular hypercontracture upon Ca 2ϩ repletion. In experiments evaluating the changes in the mag-fluo-4 fluorescence during Ca 2ϩ -free superfusion with tetracaine, tetracaine was applied from the initial superfusion with normal Tyrode solution to avoid possible artifact arising from the fluorescencequenching effect of tetracaine. 36, 37 Protocols for Administration of Sevoflurane Sevoflurane (Abbott Laboratories, North Chicago, IL) was applied for three different periods during the superfusion: for a period of initial superfusion with normal Tyrode (Pre), for a period of 3 min before and during Ca 2ϩ repletion (Post), and for a period of Ca 2ϩ depletion and repletion (Postlong). These three protocols were applied to examine the effect on the Ca 2ϩ paradox, whereas Post and Postlong protocols were used to assess the SR Ca 2ϩ levels. Sevoflurane was equilibrated in normal Tyrode and/or nominally Ca 2ϩ -free Tyrode solutions, or nisoldipine-containing K ϩ -free Tyrode solution in a reservoir by passing air (flow rate, 0.5 l/min) through a calibrated vaporizer for at least 15 min before superfusing ventricular myocytes. The concentration of sevoflurane in normal Tyrode solution at the recording chamber was measured by gas chromatography.
Whole Cell Patch-Clamp Recordings
Ventricular myocytes were voltage-clamped using the whole cell patch-clamp technique 38 with an EPC-8 patch-clamp amplifier (HEKA, Lambrecht, Germany). Fire-polished pipettes pulled from borosilicate glass capillaries (Narishige Scientific Instrument Laboratory, Tokyo, Japan) had a resistance of 2.0 -3.5 M⍀ when filled with the pipette solution. An aliquot of cell (ventricular myocyte) suspension was transferred to a recording chamber (0.5 ml in volume) mounted on the stage of a Nikon TMD-300 inverted microscope (Tokyo, Japan) and was allowed to adhere lightly to the glass bottom for at least 1-2 min. The chamber was continuously perfused at a constant rate of 2 ml/min with bathing solutions at 34 -36°C. The voltage ramp protocol (dV/dt ϭ Ϯ0.25 V/s) was repeated every 8 s and consisted of three phases: an initial ϩ 50 mV depolarizing phase from a holding potential of 0 mV, a second hyperpolarizing phase of Ϫ150 mV, and then a third phase returning to the holding potential. The current-voltage relationship was measured during the second hyperpolarizing phase. Voltage-clamp protocols and data acquisition were controlled with PATCHMASTER software (Version 1.03, HEKA), and current records were filtered at 1 kHz, digitized at 5 kHz through an LIH-1600 interface (HEKA), and stored on a Macintosh computer. Current amplitude was presented as current density (in pA/pF), obtained by normalizing with reference to cell membrane capacitance.
Statistical Analysis
The effects of experimental protocols and animals on the data were initially examined by the two-way layout ANOVA (GLM procedure; SAS 9.1.3, SAS Institute, Inc., Cary, NC). This statistical analysis reveals that the mean square for animals was much smaller than the mean square for experimental protocol, which indicates that the effect of animals on the data is negligibly small in the current experiments. Data are presented as means (95% CIs), with the number of animals (cell isolations) and experiments indicated by N and n, respectively, whereas error bars in the figures represent 95% CIs with number of experiments (n) given in parentheses. Statistical comparisons between two groups were evaluated by Mann-Whitney U test and comparisons among multiple groups were performed by Kruskal-Wallis test followed by Mann-Whitney U test with Bonferroni correction, using the GraphPad Prism 5 (La Jolla, CA). All statistical tests were two-tailed. A value of P Ͻ 0.05 was considered statistically significant. 1C, panel a) accompanied by a marked decrease of length/width ratio to less than 2 ( fig. 1C, b , hypercontracture). It should be noted that there was no recovery from hypercontracture during 10 min of Ca 2ϩ repletion (data not shown). In a total of 16 experiments, the incidence of the Ca 2ϩ paradox averaged 65.6% (56.5-74.6%; n ϭ 16, N ϭ 6) under control conditions. Figure 2A summarizes the results of the effect of three different protocols (Pre, Post, and Postlong) for the application of sevoflurane on the Ca 2ϩ paradox. The incidence of the Ca 2ϩ paradox was significantly reduced by sevoflurane applied in Post (36.2%, [26.6 -45 .8%]; n ϭ 16, N ϭ 5) and Postlong (14.2%, [7.6 -20 .9%]; n ϭ 11, N ϭ 4) protocols but not in Pre protocol (62.3%, [51.4 -73 .1%]; n ϭ 10, N ϭ 4), when compared with control (65.6%, [56. .6%]; n ϭ 16, N ϭ 6). As demonstrated in figure 2B , a linear correlation was observed between the volume percentage of sevoflurane delivered via vaporizer and its millimolar concentrations in the superfusate (normal Tyrode solution), measured by gas chromatography. Figure 2C illustrates concentration-dependent effect of sevoflurane in Postlong application, which was the most protective protocol against the Ca 2ϩ paradox. The Ca 2ϩ paradox was suppressed by sevoflurane in Postlong protocol with an IC 50 of 0.14 mM (approximately1.0%, fig. 2B ). Sevoflurane was thus found to effectively suppress the Ca 2ϩ paradox even at concentrations lower than 1 minimum alveolar concentration (2.3% in mouse).
Results
Ca
Block of TRPC Channel by Sevoflurane
To elucidate the electrophysiologic and cellular mechanisms for the suppressive effect of sevoflurane on the Ca 2ϩ paradox, we examined the effect of sevoflurane on the TRPC channel current using whole cell patch-clamp method during superfusion with K ϩ -free Tyrode solution containing 1 M nisoldipine. It has been demonstrated in various cell types that thapsigargin activates the TRPC channel current by depleting SR Ca 2ϩ stores through the inhibition of sarcoplasmic/ endoplasmic reticulum Ca 2ϩ -ATPase (SERCA). 39 Bath ap- fig. 3C , 2-3). Similar properties have been reported for the TRPC1 current in submandibular gland acinar cells 39 and ventricular myocytes of mouse. 27 As demonstrated in figs. 3D-E, sevoflurane (3%) rapidly blocked the thapsigargin-induced TRPC current in a reversible manner. Similar results were obtained in four additional myocytes. These observations show that TRPC channels were blocked by sevoflurane and indicate that this blocking action could contribute to the suppressive effect of Post and Postlong applications of sevoflurane on the Ca 2ϩ paradox ( fig. 1B and D and fig. 2A ). As illustrated in figure 4 , the Ca 2ϩ paradox was markedly suppressed by 2-APB (20 M) applied for a period of 3 min before and during Ca 2ϩ restoration, which again confirms the involvement of Ca 2ϩ entry via TRPC channels in the Ca 2ϩ paradox. 27 Post application of sevoflurane together with 2-APB did not further improve the suppressive effect of 2-APB, which suggests that sevoflurane applied in Post protocol protects ventricular myocytes from the Ca 2ϩ paradox by the same mechanism as 2-APB, namely, by blocking the TRPC channels.
Preservation of SR Ca 2؉ Content by Sevoflurane as Assessed by Mag-Fluo-4 Fluorescence
However, a significant difference was detected in the suppressive effect of sevoflurane on the Ca 2ϩ paradox between Post and Postlong application protocols ( fig. 2A) . The observation that Postlong application was more effective indicates that the presence of sevoflurane during Ca 2ϩ depletion period is important for producing a further protective effect against the Ca 2ϩ paradox. A number of studies have indicated that Ca 2ϩ decrease in the SR is one of the effective triggers for the activation of TRPC channels. [17] [18] [19] In the next series of experiments, we assessed the hypothesis that sevoflurane applied during Ca 2ϩ -free superfusion prevents the decrease in SR Ca 2ϩ levels and thereby suppresses the subsequent activation of TRPC channels that enables rapid Ca 2ϩ entry leading to the Ca 2ϩ paradox upon Ca 2ϩ restoration. In recent years, the low-affinity (K D of 22 M) fluorescence Ca 2ϩ indicator mag-fluo-4 has proven useful in monitoring Ca 2ϩ levels in organelles, where free Ca 2ϩ levels are substantially high (submillimolar concentrations), such as SR and nuclear envelope. 40 To verify that mag-fluo-4 fluorescence largely reflects SR Ca 2ϩ levels in mouse ventricular myocytes, the effect of caffeine, a well-known ryanodine 2B , http://links.lww.com/ALN/A767). A similar degree of decline in mag-fluo-4 fluorescence has been found during exposure to caffeine in primary cultured rat ventricular myocytes. 40 Therefore, the mag-fluo-4 fluorescence intensity can be regarded as primarily reflecting Ca 2ϩ levels in the SR in mouse ventricular myocytes.
In the experiment shown in figure 5 , mag-fluo-4 fluorescence intensity was continuously measured to monitor SR Ca 2ϩ levels during 15 min of Ca 2ϩ -free superfusion. In control, mag-fluo-4 fluorescence was gradually decreased to approximately 80% of the initial levels measured just before Ca 2ϩ depletion ( fig. 5A and B), indicating that there is a gradual decline of SR Ca 2ϩ levels during Ca 2ϩ depletion. This decline of mag-fluo-4 fluorescence was significantly reduced by the presence of tetracaine (1 mM), a drug that potently blocks the SR Ca 2ϩ leak via RyR2, 42 suggesting that the gradual decline of SR Ca 2ϩ levels is ascribable to spontaneous Ca 2ϩ leak via RyR2. On the other hand, mag-fluo-4 fluorescence was further decreased during Ca 2ϩ -free superfusion by the addition of the SERCA inhibitor thapsigargin (1 M; fig. 5A and B), indicating that SR Ca 2ϩ depletion was facilitated by inhibiting Ca 2ϩ uptake into the SR. Thapsigargin was thus found to be effective at depleting SR Ca 2ϩ stores, which could be related to the activation of TRPC Suppression of Ca 2ϩ Paradox by Sevoflurane channels in the presence of this compound. 39 These results indicate that the SR Ca 2ϩ levels were decreased to some extent during Ca 2ϩ -free superfusion, due to the spontaneous Ca 2ϩ leak via RyR2, and that this spontaneously released Ca 2ϩ was partly reuptaken via SERCA. Figure 6 shows the effects of Post and Postlong applications of sevoflurane on the changes in SR Ca 2ϩ levels during Ca 2ϩ depletion. In Post application, the mag-fluo-4 fluorescence gradually declined during Ca 2ϩ depletion to an extent similar to control, whereas Postlong application significantly antagonized the decrease in mag-fluo-4 fluorescence ( fig. 6A and B). These observations suggest that the SR Ca 2ϩ level was considerably preserved by the presence of sevoflurane during the Ca 2ϩ -free superfusion period. To elucidate the mechanism by which sevoflurane maintains the SR Ca 2ϩ levels during Ca 2ϩ depletion, changes in mag-fluo-4 fluorescence were examined under conditions where RyR2 was blocked by tetracaine (1 mM). As demonstrated in figures 6C and D, Postlong application of sevoflurane did not cause an additional increase in mag-fluo-4 fluorescence intensity during Ca 2ϩ depletion in the presence of tetracaine ( fig. 6D ), which suggests that sevoflurane maintains the SR Ca 2ϩ levels by blocking Ca 2ϩ leak via RyR2. It was also found that mag-fluo-4 fluorescence intensity during the presence of tetracaine was not influenced by adding sevoflurane before tetracaine ( fig. 6D ). This observation further strengthens the view that sevoflurane shares the same mechanisms of action as tetracaine in maintaining the SR Ca 2ϩ levels, namely, by blocking RyR2. -depletion in the presence of tetracaine and sevoflurane as indicated. † Tetracaine was added before sevoflurane, as indicated in C; § sevoflurane was administered before tetracaine during initial superfusion with normal Tyrode solution. There was no significant difference among the three groups, except the Control (n ϭ 8, N ϭ 3 for each group). * P Ͻ 0.05 compared with Control (P ϭ 0.038 for all *). NS ϭ not significant. fig. 7A, b) .
PERIOPERATIVE MEDICINE
Functional
The individual records for control and Post application of sevoflurane were arranged into three arbitrary groups according to the values for mag-fluo-4 F/F 0 , and the incidence of the Ca 2ϩ paradox was compared between data for control and Post application of sevoflurane ( fig. 7B ). Under control conditions, the incidence of Ca 2ϩ paradox was increased with a reduction of mag-fluo-4 F/F 0 , and reached 100% when mag-fluo-4 F/F 0 was decreased to less than 0.75. These results again suggest that the Ca 2ϩ paradox was more readily evoked in myocytes with lower Ca 2ϩ levels in the SR. Consistent with this notion, the incidence of the Ca 2ϩ paradox was markedly reduced by Postlong application of sevoflurane (1 out of 18 myocytes, 5.6%), where most of the myocytes showed a higher value of mag-fluo-4 F/F 0 ( fig. 7Ac, see also  fig. 6B ). It is important to note that whereas there are no significant differences in the overall mean value ( fig. 6B ) and distribution of mag-fluo-4 F/F 0 (see Supplemental Digital Content 1, fig. 3 , http://links.lww.com/ALN/A767) between control and Post application of sevoflurane, the incidence of the Ca 2ϩ paradox was reduced by Post application in all three arbitrary groups ( fig. 7B) . Thus, Post application of sevoflurane effectively protected ventricular myocytes from the Ca 2ϩ paradox ( fig. 2A and fig. 7B ) without appreciably affecting the SR Ca 2ϩ levels, as evidenced by the changes in mag-fluo-4 F/F 0 value ( fig. 6A and B ; see Supplemental Digital Content 1, fig.  3A , http://links.lww.com/ALN/A767). This beneficial effect of Post application of sevoflurane may be ascribable to its blocking action on TRPC channels ( figs. 3 and 4) .
Our previous experiments demonstrated that tetracaine effectively prevents the occurrence of the Ca 2ϩ paradox with an 42 and suggested that tetracaine prevents the Ca 2ϩ paradox primarily by preventing the decrease in SR Ca 2ϩ levels. 27 We examined the effect of Post application of sevoflurane (3%) on the Ca 2ϩ paradox in the presence of tetracaine at 0.3 mM, where the incidence Ca 2ϩ paradox was substantially reduced (see Supplemental Digital Content 1, fig. 4 , http://links.lww.com/ALN/A767). Post application of sevoflurane was found to further suppress the Ca 2ϩ paradox. This observation again supports the view that Post application of sevoflurane prevented the Ca 2ϩ paradox by inhibiting the TRPC channels, which is a different mechanism of action of tetracaine (RyR2 block).
Discussion
Recent studies have suggested that Ca 2ϩ influx associated with SOCE mediates the ischemia/reperfusion-induced Ca 2ϩ overload in the heart. 28, 29 Because there is considerable evidence to indicate that TRPC channels contribute to SOCE in various cell types including cardiac myocytes, 17, 22, 23 these studies should suggest the important possibility that TRPC channel activation is actually involved in mediating the ischemia/reperfusion-induced Ca 2ϩ overload. It therefore appears worthwhile to examine the Ca 2ϩ paradox, which is primarily mediated via Ca 2ϩ entry via TRPC channels, 27 as an experimental model to assess the ischemia/reperfusion injury associated with the TRPC-mediated Ca 2ϩ overload. It should be noted that less Ca 2ϩ is stored in the SR during ischemia, probably due to the decreased rate of Ca 2ϩ uptake via SERCA. 43, 44 Furthermore, a recent study demonstrated that SR Ca 2ϩ level, as assessed by measuring the magfluo-4 fluorescence, is rapidly diminished at the onset of reperfusion in a Langendorff-perfused mouse heart model. 45 It may be reasonable to speculate that SR Ca 2ϩ depletion observed in ischemia and/or reperfusion is related to the activation of SOCE that may contribute to Ca 2ϩ overload after ischemia.
28,29
Block of TRPC Channels Contributes to the Preventive Action of Sevoflurane in Post and Postlong Applications against the Ca 2؉ Paradox The current experiments found that sevoflurane at clinically relevant concentrations blocks the TRPC channels ( fig. 3D-F  and fig. 4 ) and thereby prevents the Ca 2ϩ paradox in mouse ventricular myocytes ( fig. 2A) . Currently, it remains unclear whether the blocking action of sevoflurane on TRPC channels arises from direct binding to the channel proteins or is mediated indirectly by altering the behavior and dynamics of plasma membrane lipids. It is also probable that sevoflurane affects signal transduction processes associated with TRPC channel activation. It should, however, be noted that the blocking effect of sevoflurane is completely reversed within 1 min after washout ( fig. 3D-F ), which appears to be a favorable property for clinical applications. Future studies are required to elucidate the molecular and cellular signaling basis for the blocking action of sevoflurane on the TRPC channels.
Previous studies have demonstrated that sevoflurane blocks several types of ionic channels and transporters in cardiac ventricular myocytes, including the L-type Ca 2ϩ channel, 46 Na ϩ /Ca 2ϩ exchanger, 47 and plasma membrane Ca 2ϩ pump, 48 while modestly affecting the inwardly rectifying K ϩ channel. 46 The current data indicate that TRPC channels can be added to the list of cardiac ion channels modulated (inhibited) by sevoflurane.
Preservation of SR Ca
2؉ by Postlong Application of Sevoflurane and Its Contribution to Better Protection against the Ca 2؉ Paradox The current experiments using a low-affinity Ca 2ϩ fluorescence indicator mag-fluo-4 found that SR Ca 2ϩ levels were significantly better preserved by the presence of sevoflurane during Ca 2ϩ depletion (Postlong), compared with conditions where sevoflurane was absent during Ca 2ϩ depletion ( fig. 6A and B ). This effect of sevoflurane appears to involve the block of spontaneous Ca 2ϩ leak via RyR2, similar to the action of tetracaine ( fig. 6C and D) . Previous studies have also suggested that sevoflurane maintains SR Ca 2ϩ stores by blocking the spontaneous Ca 2ϩ release from the SR in rat ventricular myocytes. 49 It should be noted that sevoflurane exerts an inhibitory action on the plasma membrane Na ϩ /Ca 2ϩ exchanger 47 and Ca 2ϩ pump, 48 which could also result in Ca 2ϩ loading into the SR through the inhibition of Ca 2ϩ extrusion from the myocytes, 50 so long as there is sufficient adenosine 5Ј-triphosphate for SERCA-mediated SR Ca 2ϩ uptake. Because Ca 2ϩ depletion in the SR may act as an effective trigger for the activation of TRPC channels, [17] [18] [19] it is reasonable to propose that the better preservation of SR Ca 2ϩ levels by Postlong application of sevoflurane could result in less TRPC activation, and thereby contributes to a lower incidence of the Ca 2ϩ paradox, compared with Post application ( fig. 2A and fig. 6A and B) .
It was also found that the Ca 2ϩ paradox occurred in an all-or-none manner both in control conditions and in the presence of sevoflurane ( fig. 1 ). The precise mechanism for this phenomenon is as yet undefined. As judged from the observation that TRPC channels are permeable to Ca 2ϩ and display time-independent kinetics, 19, 51 it may be probable that once the channel opens due to SR Ca 2ϩ depletion, adequate Ca 2ϩ may enter the cell without delay to cause hypercontracture (Ca 2ϩ paradox). Even in the presence of sevoflurane applied in Postlong protocol, in myocytes where the SR Ca 2ϩ content was not maintained and/or TRPC channels were not blocked, TRPC channels may mediate sufficient Ca 2ϩ influx to cause "complete" Ca 2ϩ paradox. Additional studies are required to elucidate the ionic mechanisms associated with the occurrence of the Ca 2ϩ paradox in an all-or-none manner.
Protection of Ventricular Myocytes against Ca 2؉ Paradox by Sevoflurane and Its Possible Clinical Implications
Although many cellular mechanisms have been put forward to explain the beneficial effects of APC and APoC, the attenuation of intracellular Ca 2ϩ overload appears to be one of the fig. 2A) can be included in its APoC action. Our experiments indicate the possible presence of novel targets for APoC action by sevoflurane, namely TRPC channels and RyR2, which are different from the previously known target proteins associated with prosurvival signaling pathways, such as protein kinase C, phosphatidylinositol-3-kinase, endothelial NO synthase, glycogen synthase kinase-3␤, and mitochondrial permeability transition pore. 6,8 -10 The current experiments found that sevoflurane at clinically relevant concentrations is able to effectively prevent the Ca 2ϩ paradox that rapidly occurs after Ca 2ϩ restoration (figs. 1 and 2). The difference in the protective effects of Post and Postlong applications of sevoflurane against the Ca 2ϩ paradox can be explained as follows: Post application of sevoflurane only inhibits the TRPC channels, whereas Postlong application in addition suppresses a factor for TRPC activation, namely SR Ca 2ϩ depletion. Administration of sevoflurane on clinical reperfusion, which corresponds to the current protocol of Post application, is expected to exert a protective action against Ca 2ϩ overload during reperfusion of ischemic myocardium, mediated at least partly through the SOCE mechanism. 28, 29 Although it remains unknown as to whether and to what extent sevoflurane reaches the ischemic myocardium, continuous administration of sevoflurane even during the ischemic period (corresponding to Postlong application) is likely to produce additional beneficial effects against Ca 2ϩ overload-mediated reperfusion injury.
Limitations of the Study
Although the Ca 2ϩ overload-mediated ischemia/reperfusion injury may be at least partly reproduced by the Ca 2ϩ paradox phenomenon, some differences have also been shown to exist in the mechanisms involved in Ca 2ϩ paradox and ischemia/reperfusion injury. 15 For example, intracellular adenosine 5Ј-triphosphate is maintained during Ca 2ϩ depletion but is reduced during hypoxia/ischemia. In addition, intracellular Na ϩ overload contributes substantially to ischemia/reperfusion injury but is not a prerequisite for the Ca 2ϩ paradox upon Ca 2ϩ repletion. Furthermore, the Ca 2ϩ paradox produces more severe damage to the heart than ischemia/reperfusion injury. It may also be noted that whereas APC effectively attenuates Ca 2ϩ overload during ischemia/reperfusion, 2,5 it remains to be elucidated whether APC protects the heart from the Ca 2ϩ paradox-mediated Ca 2ϩ overload. These two types of myocardial injury thus differ in their pathomechanisms, 15 whereas SOCE appears to be relevant to Ca 2ϩ overload in both injuries. [27] [28] [29] Therefore, the current results obtained using the Ca 2ϩ paradox phenomenon cannot be directly extrapolated to myocardial Ca 2ϩ overload during ischemia/reperfusion. In addition, the current experiments conducted on isolated myocytes at room temperature (23-25°C) may not represent all of the features of the Ca 2ϩ paradox in the heart 15 where myocytes are sitting in the structured setting, connected by gap junctions (connexins) and surrounded by basal lamina. Because in clinical situations, the Ca 2ϩ paradox injury could occur during reperfusion after cardioplegic arrest or preservation with Ca 2ϩ -free cardioplegia, 52, 53 it is important to examine whether TRPC activation has any relevance to possible cardioplegic ischemia/reperfusion injury, using a whole heart model.
Conclusions
In conclusion, sevoflurane markedly suppresses the Ca 2ϩ paradox-mediated Ca 2ϩ overload by two distinct but closely related cellular mechanisms, namely by blocking TRPC channels that mediates Ca 2ϩ entry upon Ca 2ϩ repletion associated with development of the Ca 2ϩ paradox and by preventing the SR Ca 2ϩ decrease during Ca 2ϩ depletion, which is associated with less TRPC activation. These mechanisms may be involved in the cardioprotective effect of APoC in the experimental setting and are likely to provide a promising and widely applicable strategy to protect the heart from Ca 2ϩ overload-mediated injury in clinical settings.
